REG - BioVentix PLC - Result of AGM

BioventixAnnouncement

07/12/2023 15:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231207:nRSG0811Wa&default-theme=true

RNS Number : 0811W  BioVentix PLC  07 December 2023

Bioventix plc

("Bioventix" or the "Company")

 

Result of AGM

 

Bioventix plc (AIM: BVXP) a UK company specialising in the development and
commercial supply of high-affinity monoclonal antibodies for applications in
clinical diagnostics, announces that at its Annual General Meeting held
earlier today, all resolutions put to shareholders were duly passed.

 

 

For further information please contact:

 

 Bioventix plc                                          Tel: 01252 728 001

 Peter Harrison               Chief Executive Officer

 Bruce Hiscock                Chief Financial Officer

 finnCap Ltd                                            Tel: 020 7220 0500

 Geoff Nash / Simon Hicks     Corporate Finance

 Nigel Birks / Harriet Ward   ECM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGBUBDDUDGDGXR